Cisapride hydrate - CAS 260779-88-2
Catalog number: 260779-88-2
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C23H29N3O4ClFH2O
Molecular Weight:
483.96
COA:
Inquire
Targets:
5-HT Receptor
Description:
Cisapride, also called as R51619, is a serotonin 5-HT4 receptor agonist used as a gastroprokinetic agent. Cisapride stimulates gastrointestinal motility, probably by facilitating acetylcholine release at the myenteric plexus.
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥99%
Appearance:
White to beige solid powder
Synonyms:
4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide; hydrate;Cisapridemonohydrate;260779-88-2;cis-4-Amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenxamidemonohydrate;CISAPRIDEMONOHYDRATE; 81098-60-4 (Cisapride free base); 189888-25-3 (Cisapride tartrate); 260779-88-2 (Cisapride hydrate)
MSDS:
Inquire
Quantity:
Data not available, please inquire.
InChIKey:
QBYYXIDJOFZORM-IKGOIYPNSA-N
InChI:
1S/C23H29ClFN3O4.H2O/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16;/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29);1H2/t20-,22+;/m0./s1
Canonical SMILES:
COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F.O
1.Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.
Dhiman RK1, Sarkar PK, Sharma A, Vasishta K, Kohli KK, Gupta S, Suri S, Chawla Y. Dig Dis Sci. 2004 Aug;49(7-8):1335-41.
The role of female sex hormones in the pathogenesis of gallstones is well established. Pregnancy, contraceptive use, estrogen replacement therapy in postmenopausal women, and estrogen therapy in men for the treatment of prostatic carcinoma have been found to be associated with increased risk of cholesterol gallstones. Alterations in gallbladder emptying and in bile lithogenicity in postmenopausal women receiving hormone replacement therapy (HRT) have not been studied to date. The present study was undertaken to study the effect of HRT on gallbladder emptying and bile lithogenicity. Sixteen postmenopausal women were included in the study. None of the patients had gallstone disease and none had received prokinetic drugs, such as, erythromycin, metoclopramide, domperidone or cisapride, aspirin, and nonsteroidal antiinflammatory drugs. Gallbladder emptying (n = 16), bile microscopy (n = 7), cholesterol saturation index (CSI) (n = 7), and nucleation time (n = 7) were studied before and 3 months after HRT (conjugated estrogen, 0.
2.Review: pathogenesis of gallstones.
Dowling RH1. Aliment Pharmacol Ther. 2000 May;14 Suppl 2:39-47.
The aim of this article is to review selected aspects of the pathogenesis of cholesterol-rich, gall-bladder stones (GBS)--with emphasis on recent developments in biliary cholesterol saturation, cholesterol microcrystal nucleation, statis within the gall-bladder and, particularly, on the roles of intestinal transit and altered deoxycholic acid (DCA) metabolism, in GBS development. In biliary cholesterol secretion, transport and saturation, recent developments include evidence in humans and animals, that bile lipid secretion is under genetic control. Thus in mice the md-2 gene, and in humans the MDR-3 gene, encodes for a canalicular protein that acts as a 'flippase' transporting phospholipids from the inner to the outer hemi-leaflet of the canalicular membrane. In the absence of this gene, there is virtually no phospholipid or cholesterol secretion into bile. Furthermore, when inbred strains of mice that have 'lith genes' are fed a lithogenic diet, they become susceptible to high rates of GBS formation.
3.Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog.
Michiels M1, Monbaliu J, Hendriks R, Geerts R, Woestenborghs R, Heykants J. Arzneimittelforschung. 1987 Oct;37(10):1159-67.
The plasma kinetics and tissue distribution of the gastrokinetic (+/-)-cis-4-amino-5-chloro-N-[1-(3-(4-fluorophenoxy)propyl]-3-methoxy-4- piperidinyl]-2-methoxybenzamide monohydrate (cisapride, R 51 619) have been studied in the rat, rabbit and dog. After intravenous administration to rats (5 mg/kg) and dogs (0.63 mg/kg) plasma level-time curves were adequately fitted to a two-compartmental model. The plasma clearance (ClT) and volume of distribution (Vdss) averaged 91 ml/min.kg and 4.7 l/kg in the rat and 4.2 ml/min.kg and 0.82 l/kg in the dog, respectively. Following oral administration, cisapride was rapidly and almost completely absorbed from the gastrointestinal tract in rats and rabbits. The absorption was somewhat slower in the dog. In male rats the plasma radioactivity was mainly due to metabolites, unaltered cisapride representing on average 10% of the total radioactivity. A markedly larger proportion of the parent drug was seen in female rats.
4.Effects of 5-HT1A and 5-HT4 receptor agonists on slow synaptic potentials in enteric neurons.
Pan H1, Galligan JJ. Eur J Pharmacol. 1995 May 4;278(1):67-74.
Intracellular electrophysiological methods were used to examine the effects of 5-hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT), 5-methoxytryptamine (5-MeOT), 4-amino-5-chloro-2-methoxy-N-(4-[1-azabicyclo[3,3,1]nonyl]) benzamide hydrochloride (renzapride), cis-4-amino-5-chloro-N[1-[3- (4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl[-2-methoxybenzamide monohydrate (cisapride) and endo-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-3- (1-methyl)ethyl-2-oxo-1 H-benzimidazole-1-carboxamidehydrochloride (BIMU 8) on noncholineric slow excitatory postsynaptic potentials (slow EPSPs) in myenteric afterhyperpolarization (AH) neurons of guinea pig ileum. 5-HT (0.01-1 microM) and 5-CT (0.001-0.1 microM) produced a concentration-dependent inhibition of slow EPSPs. The 5-HT1A receptor antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimidobutyl]piperazine (NAN-190) produced rightward shifts in 5-HT and 5-CT concentration-response curves; facilitation of slow EPSPs was never observed.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related 5-HT Receptor Products


CAS 167710-87-4 RS 39604 hydrochloride

RS 39604 hydrochloride
(CAS: 167710-87-4)

RS 39604 is a high affinity and selective 5-HT4 receptor antagonist that is orally active and long-lasting in vivo, with a pKi of 9.1 at 5-HT4 receptors in guin...

CAS 1386928-34-2 LP 20 hydrochloride

LP 20 hydrochloride
(CAS: 1386928-34-2)

LP 20 hydrochloride is a ligand of the 5-HT7 receptor. It shows agonist and antagonist activity.

CAS 24276-84-4 Ferulic acid sodium

Ferulic acid sodium
(CAS: 24276-84-4)

Ferulic acid sodium is one of the most abundant phenolic acids ubiquitously existing in plants. Free ferulic acid is a good antioxidant since it forms a resonan...

CAS 691846-63-6 GMC 3-15

GMC 3-15
(CAS: 691846-63-6)

GMC 3-15 is a potent and selective 5-HT1B/1D antagonist.

CAS 115338-32-4 NAN-190 hydrobromide

NAN-190 hydrobromide
(CAS: 115338-32-4)

The hydrobromide salt form of NAN-190 which is an effective antagonist of 5-HT1A serotonin receptor.

CAS 181629-93-6 SB 228357

SB 228357
(CAS: 181629-93-6)

SB 228357 is a 5-HT2C/2B receptor antagonist (pKi = 7.0, 8.1 and 9.1 at 5-HT2A, 2B and 2C receptors, respectively) used in the treatment of irritable bowel synd...

CAS 150323-78-7 Quipazine dimaleate

Quipazine dimaleate
(CAS: 150323-78-7)

Quipazine dimaleate is a slective 5-HT3 receptor agonist, and also displays antagonist activity at peripheral 5-HT3 receptors. Quipazine was shown to increase s...

CAS 139290-69-0 MDL 100151

MDL 100151
(CAS: 139290-69-0)

MDL 100151 is the racemic MDL 100907 and a selective 5-HT2A antagonist.

CAS 1173022-77-9 BRL 15572 hydrochloride

BRL 15572 hydrochloride
(CAS: 1173022-77-9)

BRL 15572 hydrochloride is a selective h5-HT1D antagonist with 60-fold selectivity over h5-HT1B.

TG6-10-1
(CAS: 1415716-58-3)

TG6-10-1, a potent and selective antagonist for the prostaglandin E2 receptor subtype EP2, has been shown antagonist activity at human EP2 receptor expressed in...

CAS 99201-87-3 Anpirtoline hydrochloride

Anpirtoline hydrochloride
(CAS: 99201-87-3)

Anpirtoline hydrochloride is the hydrochloride salt of anpirtoline, which is a highly potent 5-HT1B receptor agonist with Ki values of 28 nM. It decreases centr...

BMS-180048
(CAS: 171171-42-9)

BMS-180048, also know as Avitriptan Fumarate, has been found to be a5HT-1B/1D-receptor agonist that was once studied as an anti-migraine agent.

CAS 105826-92-4 Tropisetron HCl

Tropisetron HCl
(CAS: 105826-92-4)

Tropisetron is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor. It is used mainly as a...

CAS 39731-05-0 SDZ 21009

SDZ 21009
(CAS: 39731-05-0)

SDZ 21009 is a β-adrenoceptor and 5-HT1A/1B receptor antagonist (pKB/pA2 = 8.3 and 8.0 for 5-HT1A and 5-HT1B receptors, respectively).

CAS 85650-56-2 Asenapine Maleate

Asenapine Maleate
(CAS: 85650-56-2)

Asenapine Maleate is a 5-HT receptor antagonist used for the treatment of acute schizophrenia and bipolar mania. It is a second-generation (atypical) antipsycho...

CAS 134296-40-5 BIMU 8

BIMU 8
(CAS: 134296-40-5)

BIMU 8 is a potent and selective 5-HT4 receptor full agonist (KD = 77 nM and EC50 = 18 nM for wild type 5-HT4 receptors).

CAS 162760-96-5 WAY-100635

WAY-100635
(CAS: 162760-96-5)

WAY-100635 is an achiral analogue of WAY-100135 which is significantly more potent and selective than the latter compound and which displays unequivocal 5-HTIA ...

CAS 200940-23-4 SB 243213 dihydrochloride

SB 243213 dihydrochloride
(CAS: 200940-23-4)

SB 243213 dihydrochloride is a 5-HT2C inverse agonist (pKb = 9.8) with selectivity over other 5-HT2 subtypes (pKi = 6.8, 7.0 and 9.0 for 5-HT2A, 5-HT2B and 5-HT...

CAS 144734-36-1 4F 4PP oxalate

4F 4PP oxalate
(CAS: 144734-36-1)

4F 4PP oxalate is a selective 5-HT2A antagonist with almost as high affinity (Ki = 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki = 6...

CAS 193611-72-2 BRL-15572

BRL-15572
(CAS: 193611-72-2)

BRL-15572 displays high affinity and selectivity for h5-HT1D receptors. BRL-15572 has 60-fold higher affinity for h5-HT1D than 5-HT1B receptors.

Chemical Structure

CAS 260779-88-2 Cisapride hydrate

Quick Inquiry

Verification code

Featured Items